L’Oréal Introduces Cell BioPrint for Personalized Skin Analysis at CES 2025

The device uses proteomics to predict skin aging, ingredient responsiveness, and potential future cosmetic issues.

L’Oréal unveiled the Cell BioPrint, a device that analyzes skin biomarkers in five minutes to provide personalized skincare recommendations.
Developed in partnership with Korean startup NanoEnTek, the device uses microfluidic lab-on-a-chip technology to measure protein biomarkers from a facial tape strip sample.
The Cell BioPrint predicts skin’s biological age, responsiveness to active ingredients like retinol, and potential future issues such as dark spots or enlarged pores.
The device is designed for use at beauty counters, with a pilot program planned in Asia later in 2025, though no price or consumer release date has been confirmed.
L’Oréal emphasizes the device’s aim to shift skincare from reactive to proactive, addressing frustrations with trial-and-error approaches in the $125 billion global skincare market.